nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—ABCB1—peripheral nervous system neoplasm	0.296	1	CbGaD
Eletriptan—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.0888	0.245	CbGbCtD
Eletriptan—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0319	0.0879	CbGbCtD
Eletriptan—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0319	0.0878	CbGbCtD
Eletriptan—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0319	0.0878	CbGbCtD
Eletriptan—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0305	0.0841	CbGbCtD
Eletriptan—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0221	0.0609	CbGbCtD
Eletriptan—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0191	0.0526	CbGbCtD
Eletriptan—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0178	0.0489	CbGbCtD
Eletriptan—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0136	0.0375	CbGbCtD
Eletriptan—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0131	0.036	CbGbCtD
Eletriptan—HTR1D—meninx—peripheral nervous system neoplasm	0.0127	0.129	CbGeAlD
Eletriptan—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0127	0.035	CbGbCtD
Eletriptan—HTR1F—trigeminal nerve—peripheral nervous system neoplasm	0.0127	0.129	CbGeAlD
Eletriptan—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0125	0.0343	CbGbCtD
Eletriptan—HTR1B—dura mater—peripheral nervous system neoplasm	0.0121	0.123	CbGeAlD
Eletriptan—HTR1D—dura mater—peripheral nervous system neoplasm	0.0117	0.119	CbGeAlD
Eletriptan—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00851	0.0234	CbGbCtD
Eletriptan—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00816	0.0225	CbGbCtD
Eletriptan—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00802	0.0221	CbGbCtD
Eletriptan—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00747	0.0206	CbGbCtD
Eletriptan—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.00519	0.0529	CbGeAlD
Eletriptan—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0051	0.014	CbGbCtD
Eletriptan—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.00503	0.0512	CbGeAlD
Eletriptan—HTR1F—ganglion—peripheral nervous system neoplasm	0.00457	0.0465	CbGeAlD
Eletriptan—HTR7—vagus nerve—peripheral nervous system neoplasm	0.00375	0.0381	CbGeAlD
Eletriptan—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.0037	0.0377	CbGeAlD
Eletriptan—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.00358	0.0365	CbGeAlD
Eletriptan—HTR7—cranial nerve—peripheral nervous system neoplasm	0.00285	0.0291	CbGeAlD
Eletriptan—HTR7—pons—peripheral nervous system neoplasm	0.00282	0.0287	CbGeAlD
Eletriptan—HTR1B—ganglion—peripheral nervous system neoplasm	0.00187	0.0191	CbGeAlD
Eletriptan—HTR1D—ganglion—peripheral nervous system neoplasm	0.00181	0.0185	CbGeAlD
Eletriptan—HTR1E—brainstem—peripheral nervous system neoplasm	0.00172	0.0175	CbGeAlD
Eletriptan—HTR1A—ganglion—peripheral nervous system neoplasm	0.00151	0.0154	CbGeAlD
Eletriptan—HTR7—nerve—peripheral nervous system neoplasm	0.00146	0.0149	CbGeAlD
Eletriptan—HTR7—ganglion—peripheral nervous system neoplasm	0.00144	0.0147	CbGeAlD
Eletriptan—PTGS1—ganglion—peripheral nervous system neoplasm	0.000998	0.0102	CbGeAlD
Eletriptan—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00092	0.00937	CbGeAlD
Eletriptan—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.000891	0.00907	CbGeAlD
Eletriptan—HTR1B—brainstem—peripheral nervous system neoplasm	0.000814	0.00829	CbGeAlD
Eletriptan—HTR1D—brainstem—peripheral nervous system neoplasm	0.000788	0.00802	CbGeAlD
Eletriptan—HTR1A—brainstem—peripheral nervous system neoplasm	0.000657	0.00669	CbGeAlD
Eletriptan—HTR7—brainstem—peripheral nervous system neoplasm	0.000628	0.00639	CbGeAlD
Eletriptan—CYP2A6—cerebellum—peripheral nervous system neoplasm	0.00047	0.00479	CbGeAlD
Eletriptan—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000357	0.00363	CbGeAlD
Eletriptan—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000324	0.0033	CbGeAlD
Eletriptan—HTR7—cerebellum—peripheral nervous system neoplasm	0.00031	0.00315	CbGeAlD
Eletriptan—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.00029	0.00295	CbGeAlD
Eletriptan—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000176	0.00179	CbGeAlD
Eletriptan—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000127	0.00129	CbGeAlD
Eletriptan—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000493	CcSEcCtD
Eletriptan—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000493	CcSEcCtD
Eletriptan—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000115	0.00049	CcSEcCtD
Eletriptan—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000115	0.000488	CcSEcCtD
Eletriptan—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000115	0.000488	CcSEcCtD
Eletriptan—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000115	0.000488	CcSEcCtD
Eletriptan—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000487	CcSEcCtD
Eletriptan—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000487	CcSEcCtD
Eletriptan—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000114	0.000486	CcSEcCtD
Eletriptan—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000484	CcSEcCtD
Eletriptan—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000113	0.000484	CcSEcCtD
Eletriptan—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000482	CcSEcCtD
Eletriptan—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000113	0.00048	CcSEcCtD
Eletriptan—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000112	0.000477	CcSEcCtD
Eletriptan—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000111	0.000475	CcSEcCtD
Eletriptan—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000474	CcSEcCtD
Eletriptan—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000111	0.000473	CcSEcCtD
Eletriptan—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000111	0.000472	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000111	0.000471	CcSEcCtD
Eletriptan—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00011	0.000467	CcSEcCtD
Eletriptan—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000467	CcSEcCtD
Eletriptan—Pain—Cisplatin—peripheral nervous system neoplasm	0.00011	0.000467	CcSEcCtD
Eletriptan—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000466	CcSEcCtD
Eletriptan—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.00046	CcSEcCtD
Eletriptan—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000459	CcSEcCtD
Eletriptan—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000456	CcSEcCtD
Eletriptan—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000456	CcSEcCtD
Eletriptan—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000456	CcSEcCtD
Eletriptan—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000456	CcSEcCtD
Eletriptan—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000107	0.000455	CcSEcCtD
Eletriptan—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000106	0.000453	CcSEcCtD
Eletriptan—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000106	0.00045	CcSEcCtD
Eletriptan—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000105	0.000449	CcSEcCtD
Eletriptan—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000449	CcSEcCtD
Eletriptan—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000446	CcSEcCtD
Eletriptan—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000105	0.000446	CcSEcCtD
Eletriptan—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000445	CcSEcCtD
Eletriptan—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000104	0.000445	CcSEcCtD
Eletriptan—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000444	CcSEcCtD
Eletriptan—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000104	0.000443	CcSEcCtD
Eletriptan—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000103	0.00044	CcSEcCtD
Eletriptan—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000103	0.00044	CcSEcCtD
Eletriptan—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000439	CcSEcCtD
Eletriptan—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000103	0.000439	CcSEcCtD
Eletriptan—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000102	0.000436	CcSEcCtD
Eletriptan—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000102	0.000435	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000101	0.000432	CcSEcCtD
Eletriptan—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000101	0.000432	CcSEcCtD
Eletriptan—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000101	0.000431	CcSEcCtD
Eletriptan—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000431	CcSEcCtD
Eletriptan—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000429	CcSEcCtD
Eletriptan—Constipation—Etoposide—peripheral nervous system neoplasm	0.0001	0.000428	CcSEcCtD
Eletriptan—Pain—Etoposide—peripheral nervous system neoplasm	0.0001	0.000428	CcSEcCtD
Eletriptan—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000427	CcSEcCtD
Eletriptan—Dizziness—Alitretinoin—peripheral nervous system neoplasm	9.94e-05	0.000424	CcSEcCtD
Eletriptan—Diarrhoea—Vincristine—peripheral nervous system neoplasm	9.91e-05	0.000423	CcSEcCtD
Eletriptan—Sweating—Epirubicin—peripheral nervous system neoplasm	9.89e-05	0.000422	CcSEcCtD
Eletriptan—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	9.89e-05	0.000422	CcSEcCtD
Eletriptan—Weight increased—Doxorubicin—peripheral nervous system neoplasm	9.74e-05	0.000415	CcSEcCtD
Eletriptan—Epistaxis—Epirubicin—peripheral nervous system neoplasm	9.73e-05	0.000415	CcSEcCtD
Eletriptan—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	9.69e-05	0.000413	CcSEcCtD
Eletriptan—Sinusitis—Epirubicin—peripheral nervous system neoplasm	9.68e-05	0.000413	CcSEcCtD
Eletriptan—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	9.67e-05	0.000412	CcSEcCtD
Eletriptan—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	9.66e-05	0.000412	CcSEcCtD
Eletriptan—Nausea—Dactinomycin—peripheral nervous system neoplasm	9.63e-05	0.000411	CcSEcCtD
Eletriptan—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	9.6e-05	0.000409	CcSEcCtD
Eletriptan—Dizziness—Vincristine—peripheral nervous system neoplasm	9.58e-05	0.000408	CcSEcCtD
Eletriptan—Vomiting—Alitretinoin—peripheral nervous system neoplasm	9.56e-05	0.000408	CcSEcCtD
Eletriptan—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	9.55e-05	0.000407	CcSEcCtD
Eletriptan—Rash—Alitretinoin—peripheral nervous system neoplasm	9.48e-05	0.000404	CcSEcCtD
Eletriptan—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	9.47e-05	0.000404	CcSEcCtD
Eletriptan—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	9.44e-05	0.000402	CcSEcCtD
Eletriptan—Bradycardia—Epirubicin—peripheral nervous system neoplasm	9.43e-05	0.000402	CcSEcCtD
Eletriptan—Headache—Alitretinoin—peripheral nervous system neoplasm	9.42e-05	0.000402	CcSEcCtD
Eletriptan—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	9.36e-05	0.000399	CcSEcCtD
Eletriptan—Urticaria—Etoposide—peripheral nervous system neoplasm	9.32e-05	0.000397	CcSEcCtD
Eletriptan—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	9.3e-05	0.000397	CcSEcCtD
Eletriptan—Rhinitis—Epirubicin—peripheral nervous system neoplasm	9.28e-05	0.000396	CcSEcCtD
Eletriptan—Body temperature increased—Etoposide—peripheral nervous system neoplasm	9.28e-05	0.000395	CcSEcCtD
Eletriptan—Abdominal pain—Etoposide—peripheral nervous system neoplasm	9.28e-05	0.000395	CcSEcCtD
Eletriptan—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	9.28e-05	0.000395	CcSEcCtD
Eletriptan—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.000393	CcSEcCtD
Eletriptan—Vomiting—Vincristine—peripheral nervous system neoplasm	9.21e-05	0.000393	CcSEcCtD
Eletriptan—Asthenia—Cisplatin—peripheral nervous system neoplasm	9.19e-05	0.000392	CcSEcCtD
Eletriptan—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	9.19e-05	0.000392	CcSEcCtD
Eletriptan—Sweating—Doxorubicin—peripheral nervous system neoplasm	9.15e-05	0.00039	CcSEcCtD
Eletriptan—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	9.15e-05	0.00039	CcSEcCtD
Eletriptan—Rash—Vincristine—peripheral nervous system neoplasm	9.14e-05	0.000389	CcSEcCtD
Eletriptan—Dermatitis—Vincristine—peripheral nervous system neoplasm	9.13e-05	0.000389	CcSEcCtD
Eletriptan—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	9.12e-05	0.000389	CcSEcCtD
Eletriptan—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	9.08e-05	0.000387	CcSEcCtD
Eletriptan—Headache—Vincristine—peripheral nervous system neoplasm	9.08e-05	0.000387	CcSEcCtD
Eletriptan—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	9e-05	0.000384	CcSEcCtD
Eletriptan—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	8.96e-05	0.000382	CcSEcCtD
Eletriptan—Nausea—Alitretinoin—peripheral nervous system neoplasm	8.93e-05	0.000381	CcSEcCtD
Eletriptan—Visual impairment—Epirubicin—peripheral nervous system neoplasm	8.92e-05	0.00038	CcSEcCtD
Eletriptan—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.77e-05	0.000374	CcSEcCtD
Eletriptan—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.000372	CcSEcCtD
Eletriptan—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	8.65e-05	0.000369	CcSEcCtD
Eletriptan—Tinnitus—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.000368	CcSEcCtD
Eletriptan—Nausea—Vincristine—peripheral nervous system neoplasm	8.61e-05	0.000367	CcSEcCtD
Eletriptan—Flushing—Epirubicin—peripheral nervous system neoplasm	8.6e-05	0.000366	CcSEcCtD
Eletriptan—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.000366	CcSEcCtD
Eletriptan—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	0.000363	CcSEcCtD
Eletriptan—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	8.5e-05	0.000362	CcSEcCtD
Eletriptan—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	8.46e-05	0.000361	CcSEcCtD
Eletriptan—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	8.44e-05	0.00036	CcSEcCtD
Eletriptan—Asthenia—Etoposide—peripheral nervous system neoplasm	8.42e-05	0.000359	CcSEcCtD
Eletriptan—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	8.4e-05	0.000358	CcSEcCtD
Eletriptan—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	8.37e-05	0.000357	CcSEcCtD
Eletriptan—Chills—Epirubicin—peripheral nervous system neoplasm	8.31e-05	0.000354	CcSEcCtD
Eletriptan—Pruritus—Etoposide—peripheral nervous system neoplasm	8.3e-05	0.000354	CcSEcCtD
Eletriptan—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000353	CcSEcCtD
Eletriptan—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	8.26e-05	0.000352	CcSEcCtD
Eletriptan—Alopecia—Epirubicin—peripheral nervous system neoplasm	8.18e-05	0.000349	CcSEcCtD
Eletriptan—Vomiting—Cisplatin—peripheral nervous system neoplasm	8.15e-05	0.000347	CcSEcCtD
Eletriptan—Rash—Cisplatin—peripheral nervous system neoplasm	8.08e-05	0.000344	CcSEcCtD
Eletriptan—Dermatitis—Cisplatin—peripheral nervous system neoplasm	8.07e-05	0.000344	CcSEcCtD
Eletriptan—Diarrhoea—Etoposide—peripheral nervous system neoplasm	8.03e-05	0.000342	CcSEcCtD
Eletriptan—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	7.99e-05	0.000341	CcSEcCtD
Eletriptan—Flushing—Doxorubicin—peripheral nervous system neoplasm	7.95e-05	0.000339	CcSEcCtD
Eletriptan—Flatulence—Epirubicin—peripheral nervous system neoplasm	7.94e-05	0.000339	CcSEcCtD
Eletriptan—Tension—Epirubicin—peripheral nervous system neoplasm	7.91e-05	0.000337	CcSEcCtD
Eletriptan—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	7.89e-05	0.000336	CcSEcCtD
Eletriptan—Nervousness—Epirubicin—peripheral nervous system neoplasm	7.83e-05	0.000334	CcSEcCtD
Eletriptan—Back pain—Epirubicin—peripheral nervous system neoplasm	7.8e-05	0.000332	CcSEcCtD
Eletriptan—Dizziness—Etoposide—peripheral nervous system neoplasm	7.76e-05	0.000331	CcSEcCtD
Eletriptan—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	7.75e-05	0.00033	CcSEcCtD
Eletriptan—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	7.74e-05	0.00033	CcSEcCtD
Eletriptan—Chills—Doxorubicin—peripheral nervous system neoplasm	7.69e-05	0.000328	CcSEcCtD
Eletriptan—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.000326	CcSEcCtD
Eletriptan—Nausea—Cisplatin—peripheral nervous system neoplasm	7.61e-05	0.000324	CcSEcCtD
Eletriptan—Alopecia—Doxorubicin—peripheral nervous system neoplasm	7.57e-05	0.000323	CcSEcCtD
Eletriptan—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	7.48e-05	0.000319	CcSEcCtD
Eletriptan—Vomiting—Etoposide—peripheral nervous system neoplasm	7.46e-05	0.000318	CcSEcCtD
Eletriptan—Anaemia—Epirubicin—peripheral nervous system neoplasm	7.45e-05	0.000318	CcSEcCtD
Eletriptan—Agitation—Epirubicin—peripheral nervous system neoplasm	7.41e-05	0.000316	CcSEcCtD
Eletriptan—Rash—Etoposide—peripheral nervous system neoplasm	7.4e-05	0.000315	CcSEcCtD
Eletriptan—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.39e-05	0.000315	CcSEcCtD
Eletriptan—Headache—Etoposide—peripheral nervous system neoplasm	7.35e-05	0.000313	CcSEcCtD
Eletriptan—Flatulence—Doxorubicin—peripheral nervous system neoplasm	7.35e-05	0.000313	CcSEcCtD
Eletriptan—Tension—Doxorubicin—peripheral nervous system neoplasm	7.32e-05	0.000312	CcSEcCtD
Eletriptan—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	7.3e-05	0.000311	CcSEcCtD
Eletriptan—Malaise—Epirubicin—peripheral nervous system neoplasm	7.27e-05	0.00031	CcSEcCtD
Eletriptan—Nervousness—Doxorubicin—peripheral nervous system neoplasm	7.25e-05	0.000309	CcSEcCtD
Eletriptan—Vertigo—Epirubicin—peripheral nervous system neoplasm	7.24e-05	0.000309	CcSEcCtD
Eletriptan—Syncope—Epirubicin—peripheral nervous system neoplasm	7.23e-05	0.000308	CcSEcCtD
Eletriptan—Leukopenia—Epirubicin—peripheral nervous system neoplasm	7.22e-05	0.000308	CcSEcCtD
Eletriptan—Back pain—Doxorubicin—peripheral nervous system neoplasm	7.22e-05	0.000308	CcSEcCtD
Eletriptan—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000306	CcSEcCtD
Eletriptan—Palpitations—Epirubicin—peripheral nervous system neoplasm	7.12e-05	0.000304	CcSEcCtD
Eletriptan—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.000302	CcSEcCtD
Eletriptan—Cough—Epirubicin—peripheral nervous system neoplasm	7.04e-05	0.0003	CcSEcCtD
Eletriptan—Convulsion—Epirubicin—peripheral nervous system neoplasm	6.99e-05	0.000298	CcSEcCtD
Eletriptan—Nausea—Etoposide—peripheral nervous system neoplasm	6.97e-05	0.000297	CcSEcCtD
Eletriptan—Hypertension—Epirubicin—peripheral nervous system neoplasm	6.96e-05	0.000297	CcSEcCtD
Eletriptan—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	6.92e-05	0.000295	CcSEcCtD
Eletriptan—Anaemia—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000294	CcSEcCtD
Eletriptan—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.000293	CcSEcCtD
Eletriptan—Myalgia—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.000293	CcSEcCtD
Eletriptan—Agitation—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	0.000292	CcSEcCtD
Eletriptan—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.84e-05	0.000292	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	6.82e-05	0.000291	CcSEcCtD
Eletriptan—Discomfort—Epirubicin—peripheral nervous system neoplasm	6.78e-05	0.000289	CcSEcCtD
Eletriptan—Malaise—Doxorubicin—peripheral nervous system neoplasm	6.73e-05	0.000287	CcSEcCtD
Eletriptan—Dry mouth—Epirubicin—peripheral nervous system neoplasm	6.71e-05	0.000286	CcSEcCtD
Eletriptan—Vertigo—Doxorubicin—peripheral nervous system neoplasm	6.7e-05	0.000286	CcSEcCtD
Eletriptan—Syncope—Doxorubicin—peripheral nervous system neoplasm	6.69e-05	0.000285	CcSEcCtD
Eletriptan—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.000285	CcSEcCtD
Eletriptan—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000283	CcSEcCtD
Eletriptan—Palpitations—Doxorubicin—peripheral nervous system neoplasm	6.59e-05	0.000281	CcSEcCtD
Eletriptan—Oedema—Epirubicin—peripheral nervous system neoplasm	6.58e-05	0.00028	CcSEcCtD
Eletriptan—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000279	CcSEcCtD
Eletriptan—Cough—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.000277	CcSEcCtD
Eletriptan—Shock—Epirubicin—peripheral nervous system neoplasm	6.47e-05	0.000276	CcSEcCtD
Eletriptan—Convulsion—Doxorubicin—peripheral nervous system neoplasm	6.46e-05	0.000275	CcSEcCtD
Eletriptan—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	6.45e-05	0.000275	CcSEcCtD
Eletriptan—Hypertension—Doxorubicin—peripheral nervous system neoplasm	6.44e-05	0.000275	CcSEcCtD
Eletriptan—Tachycardia—Epirubicin—peripheral nervous system neoplasm	6.42e-05	0.000274	CcSEcCtD
Eletriptan—Skin disorder—Epirubicin—peripheral nervous system neoplasm	6.39e-05	0.000272	CcSEcCtD
Eletriptan—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	6.36e-05	0.000271	CcSEcCtD
Eletriptan—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	6.35e-05	0.000271	CcSEcCtD
Eletriptan—Myalgia—Doxorubicin—peripheral nervous system neoplasm	6.35e-05	0.000271	CcSEcCtD
Eletriptan—Anxiety—Doxorubicin—peripheral nervous system neoplasm	6.33e-05	0.00027	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	6.31e-05	0.000269	CcSEcCtD
Eletriptan—Discomfort—Doxorubicin—peripheral nervous system neoplasm	6.27e-05	0.000267	CcSEcCtD
Eletriptan—Anorexia—Epirubicin—peripheral nervous system neoplasm	6.27e-05	0.000267	CcSEcCtD
Eletriptan—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	6.21e-05	0.000265	CcSEcCtD
Eletriptan—Hypotension—Epirubicin—peripheral nervous system neoplasm	6.15e-05	0.000262	CcSEcCtD
Eletriptan—Confusional state—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000262	CcSEcCtD
Eletriptan—Oedema—Doxorubicin—peripheral nervous system neoplasm	6.09e-05	0.000259	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.99e-05	0.000256	CcSEcCtD
Eletriptan—Shock—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	0.000255	CcSEcCtD
Eletriptan—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.97e-05	0.000254	CcSEcCtD
Eletriptan—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.95e-05	0.000254	CcSEcCtD
Eletriptan—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	5.94e-05	0.000253	CcSEcCtD
Eletriptan—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	5.91e-05	0.000252	CcSEcCtD
Eletriptan—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.91e-05	0.000252	CcSEcCtD
Eletriptan—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.89e-05	0.000251	CcSEcCtD
Eletriptan—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.87e-05	0.00025	CcSEcCtD
Eletriptan—Somnolence—Epirubicin—peripheral nervous system neoplasm	5.85e-05	0.000249	CcSEcCtD
Eletriptan—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.8e-05	0.000247	CcSEcCtD
Eletriptan—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.000247	CcSEcCtD
Eletriptan—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.72e-05	0.000244	CcSEcCtD
Eletriptan—Hypotension—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.000242	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.68e-05	0.000242	CcSEcCtD
Eletriptan—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.67e-05	0.000242	CcSEcCtD
Eletriptan—Constipation—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.00024	CcSEcCtD
Eletriptan—Pain—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.00024	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.55e-05	0.000236	CcSEcCtD
Eletriptan—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.51e-05	0.000235	CcSEcCtD
Eletriptan—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.47e-05	0.000233	CcSEcCtD
Eletriptan—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000231	CcSEcCtD
Eletriptan—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.42e-05	0.000231	CcSEcCtD
Eletriptan—Somnolence—Doxorubicin—peripheral nervous system neoplasm	5.41e-05	0.000231	CcSEcCtD
Eletriptan—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.38e-05	0.000229	CcSEcCtD
Eletriptan—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.000228	CcSEcCtD
Eletriptan—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.29e-05	0.000226	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.26e-05	0.000224	CcSEcCtD
Eletriptan—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.000224	CcSEcCtD
Eletriptan—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.000223	CcSEcCtD
Eletriptan—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000222	CcSEcCtD
Eletriptan—Pain—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000222	CcSEcCtD
Eletriptan—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.2e-05	0.000222	CcSEcCtD
Eletriptan—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.2e-05	0.000222	CcSEcCtD
Eletriptan—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.02e-05	0.000214	CcSEcCtD
Eletriptan—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.98e-05	0.000212	CcSEcCtD
Eletriptan—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.85e-05	0.000207	CcSEcCtD
Eletriptan—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.84e-05	0.000206	CcSEcCtD
Eletriptan—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.81e-05	0.000205	CcSEcCtD
Eletriptan—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.81e-05	0.000205	CcSEcCtD
Eletriptan—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.72e-05	0.000201	CcSEcCtD
Eletriptan—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.66e-05	0.000198	CcSEcCtD
Eletriptan—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000192	CcSEcCtD
Eletriptan—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.49e-05	0.000191	CcSEcCtD
Eletriptan—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000186	CcSEcCtD
Eletriptan—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.000185	CcSEcCtD
Eletriptan—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.31e-05	0.000184	CcSEcCtD
Eletriptan—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.18e-05	0.000178	CcSEcCtD
Eletriptan—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	0.000178	CcSEcCtD
Eletriptan—Rash—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000177	CcSEcCtD
Eletriptan—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.000177	CcSEcCtD
Eletriptan—Headache—Epirubicin—peripheral nervous system neoplasm	4.12e-05	0.000176	CcSEcCtD
Eletriptan—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000172	CcSEcCtD
Eletriptan—Nausea—Epirubicin—peripheral nervous system neoplasm	3.91e-05	0.000167	CcSEcCtD
Eletriptan—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.000165	CcSEcCtD
Eletriptan—Rash—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000164	CcSEcCtD
Eletriptan—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000163	CcSEcCtD
Eletriptan—Headache—Doxorubicin—peripheral nervous system neoplasm	3.81e-05	0.000163	CcSEcCtD
Eletriptan—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.62e-05	0.000154	CcSEcCtD
Eletriptan—HTR1A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.25e-05	0.00162	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.25e-05	0.00162	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.24e-05	0.00161	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.24e-05	0.0016	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.24e-05	0.0016	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.22e-05	0.00157	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.21e-05	0.00157	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.2e-05	0.00155	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.19e-05	0.00154	CbGpPWpGaD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	1.15e-05	0.00148	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.15e-05	0.00148	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.14e-05	0.00148	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GNS—peripheral nervous system neoplasm	1.12e-05	0.00144	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.09e-05	0.00141	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.09e-05	0.0014	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	1.07e-05	0.00138	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.07e-05	0.00138	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.06e-05	0.00137	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GNS—peripheral nervous system neoplasm	1.06e-05	0.00136	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	1.03e-05	0.00133	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—NME1—peripheral nervous system neoplasm	1.01e-05	0.00131	CbGpPWpGaD
Eletriptan—HTR7—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	1.01e-05	0.00131	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.01e-05	0.0013	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	9.99e-06	0.00129	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	9.93e-06	0.00128	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—VIP—peripheral nervous system neoplasm	9.9e-06	0.00128	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	9.87e-06	0.00127	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—VIP—peripheral nervous system neoplasm	9.83e-06	0.00127	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—COX2—peripheral nervous system neoplasm	9.75e-06	0.00126	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	9.68e-06	0.00125	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	9.66e-06	0.00125	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—VIP—peripheral nervous system neoplasm	9.63e-06	0.00124	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	9.56e-06	0.00123	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	9.5e-06	0.00123	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	9.38e-06	0.00121	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	9.3e-06	0.0012	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	9.28e-06	0.0012	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	9.13e-06	0.00118	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.11e-06	0.00118	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	9.08e-06	0.00117	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	9.07e-06	0.00117	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—VIP—peripheral nervous system neoplasm	9.04e-06	0.00117	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.91e-06	0.00115	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	8.88e-06	0.00115	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.84e-06	0.00114	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	8.74e-06	0.00113	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.7e-06	0.00112	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.69e-06	0.00112	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	8.68e-06	0.00112	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	8.63e-06	0.00111	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.6e-06	0.00111	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	8.45e-06	0.00109	CbGpPWpGaD
Eletriptan—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	8.39e-06	0.00108	CbGpPWpGaD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	8.38e-06	0.00108	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	8.34e-06	0.00108	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.2e-06	0.00106	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.19e-06	0.00106	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.13e-06	0.00105	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	8.1e-06	0.00105	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.97e-06	0.00103	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	7.94e-06	0.00102	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.93e-06	0.00102	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.52e-06	0.000971	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.41e-06	0.000956	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.36e-06	0.00095	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.33e-06	0.000947	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	7.3e-06	0.000942	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.09e-06	0.000915	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.86e-06	0.000885	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.81e-06	0.00088	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	6.77e-06	0.000874	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.77e-06	0.000874	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.75e-06	0.000872	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.67e-06	0.000861	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	6.62e-06	0.000855	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.56e-06	0.000846	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	6.44e-06	0.000832	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.44e-06	0.000831	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ENO2—peripheral nervous system neoplasm	6.4e-06	0.000827	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	6.29e-06	0.000812	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.27e-06	0.000809	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	6.18e-06	0.000797	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6.04e-06	0.000779	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	6.03e-06	0.000778	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6e-06	0.000774	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	5.95e-06	0.000768	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	5.93e-06	0.000765	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	5.88e-06	0.000758	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.87e-06	0.000758	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.87e-06	0.000757	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.83e-06	0.000752	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	5.8e-06	0.000749	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	5.72e-06	0.000739	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.71e-06	0.000737	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	5.68e-06	0.000733	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.64e-06	0.000728	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	5.63e-06	0.000727	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.59e-06	0.000722	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.55e-06	0.000717	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.54e-06	0.000715	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.52e-06	0.000712	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	5.47e-06	0.000706	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.46e-06	0.000705	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.44e-06	0.000702	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	5.42e-06	0.0007	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—BCHE—peripheral nervous system neoplasm	5.41e-06	0.000698	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	5.38e-06	0.000694	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.36e-06	0.000692	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.36e-06	0.000692	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.32e-06	0.000687	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.28e-06	0.000681	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.22e-06	0.000674	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5.17e-06	0.000668	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.16e-06	0.000666	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.13e-06	0.000662	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.11e-06	0.00066	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.1e-06	0.000658	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—TH—peripheral nervous system neoplasm	5.09e-06	0.000657	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.08e-06	0.000656	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.99e-06	0.000644	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.69e-06	0.000605	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.47e-06	0.000577	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	4.39e-06	0.000567	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.38e-06	0.000565	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.35e-06	0.000561	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.31e-06	0.000556	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.25e-06	0.000548	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	4.15e-06	0.000536	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.14e-06	0.000535	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.13e-06	0.000533	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.12e-06	0.000532	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	4.07e-06	0.000526	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.01e-06	0.000518	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.97e-06	0.000513	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	3.9e-06	0.000504	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.89e-06	0.000502	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	3.87e-06	0.0005	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	3.81e-06	0.000492	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.8e-06	0.000491	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.78e-06	0.000488	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.75e-06	0.000484	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	3.71e-06	0.00048	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.64e-06	0.00047	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.63e-06	0.000468	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.61e-06	0.000465	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	3.59e-06	0.000463	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.59e-06	0.000463	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	3.58e-06	0.000462	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.57e-06	0.00046	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	3.56e-06	0.000459	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.54e-06	0.000457	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.53e-06	0.000456	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.47e-06	0.000448	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.44e-06	0.000443	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.33e-06	0.00043	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.32e-06	0.000428	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	3.3e-06	0.000426	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.26e-06	0.000421	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	3.22e-06	0.000416	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.15e-06	0.000406	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.14e-06	0.000406	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.1e-06	0.0004	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	3.1e-06	0.0004	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.07e-06	0.000396	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	3.03e-06	0.000392	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	3.03e-06	0.000391	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	3.01e-06	0.000388	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.93e-06	0.000378	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.89e-06	0.000374	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.87e-06	0.00037	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	2.85e-06	0.000368	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	2.83e-06	0.000365	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.82e-06	0.000364	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.8e-06	0.000361	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.74e-06	0.000354	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.69e-06	0.000347	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.65e-06	0.000343	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.64e-06	0.000341	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.64e-06	0.00034	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.58e-06	0.000333	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.58e-06	0.000333	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.57e-06	0.000332	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.56e-06	0.000331	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.56e-06	0.00033	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.55e-06	0.000329	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.54e-06	0.000328	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	2.53e-06	0.000327	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.51e-06	0.000324	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.49e-06	0.000321	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	2.48e-06	0.000321	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	2.47e-06	0.000319	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.44e-06	0.000315	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.43e-06	0.000313	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.4e-06	0.00031	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.36e-06	0.000305	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	2.35e-06	0.000303	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.34e-06	0.000303	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.34e-06	0.000302	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.33e-06	0.000301	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	2.33e-06	0.000301	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	2.31e-06	0.000298	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.3e-06	0.000297	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.28e-06	0.000295	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.28e-06	0.000294	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	2.27e-06	0.000292	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.15e-06	0.000278	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.14e-06	0.000277	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.14e-06	0.000277	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.13e-06	0.000275	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.09e-06	0.00027	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.09e-06	0.000269	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.03e-06	0.000262	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	2e-06	0.000258	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.98e-06	0.000256	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.98e-06	0.000256	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.97e-06	0.000254	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.96e-06	0.000253	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.94e-06	0.000251	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.91e-06	0.000247	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.9e-06	0.000245	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.89e-06	0.000244	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.86e-06	0.000241	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.82e-06	0.000236	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.74e-06	0.000224	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.64e-06	0.000212	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.63e-06	0.00021	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.6e-06	0.000206	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.59e-06	0.000205	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.57e-06	0.000202	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.56e-06	0.000201	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.53e-06	0.000197	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.52e-06	0.000197	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.5e-06	0.000193	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.49e-06	0.000193	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.48e-06	0.000191	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.43e-06	0.000185	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.38e-06	0.000179	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.38e-06	0.000178	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.35e-06	0.000174	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.27e-06	0.000163	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.22e-06	0.000157	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	1.19e-06	0.000153	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.16e-06	0.00015	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	1.12e-06	0.000145	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.03e-06	0.000132	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	6.83e-07	8.82e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	6.67e-07	8.61e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	6.29e-07	8.11e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	6.23e-07	8.04e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	4.11e-07	5.3e-05	CbGpPWpGaD
